agilon health, inc. (NYSE:AGL) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Adam Ron - Bank of America George Hill - Deutsche Bank Sameer Patel - Evercore Ryan Langston - TD Cowen Stephen Baxter - Wells Fargo Andrew Mok - Barclays Jack Slevin - Jefferies Mich ...

Those who follow my work closely know that I have a pretty solid track record with my investment calls. But every so often, I, like anybody else, can make a mistake. Admitting to shortcomings is one of the most important things that Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential. Subscribers get to use a 50+ stock model account, in-depth cash ...

Agilon Health (AGL) reported $1.45 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 19.4%. EPS of -$0.29 for the same period compares to -$0.06 a year ago.The reported revenue represents a surprise of -1.29% over the Zacks Consensus Estimate of $1.47 billion. With the consensus EPS estimate being -$0.10, the EPS surprise was -190.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to d ...

Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -190%. A quarter ago, it was expected that this senior-focused health care company would post a loss of $0.07 per share when it actually produced a loss of $0.07, delivering no surprise.Over the last four quarters, the compan ...

Table of Contents Emerging Growth Company o UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...

Exhibit 99.1 agilon health Reports Third Quarter 2024 Results Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends AUSTIN, T.X., November 7 ...

Maskot One of the dangerous things about investing in companies that generate consistent losses and cash outflows is that things have to go really well or else shares risk dropping rather significantly. A great example of this can be seen by looking at agilon health (NYSE:AGL) over the last couple of days. On August 14th, shares of the company closed down 8.1% after management announced financial results covering the second quarter of the 2024 fiscal year. And if that wasn't enough, shares fell another ...

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection w ...

Magilon health, inc. (NYSE:AGL) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Adam Ron - Bank of America. Eduardo Ron - Truist George Hill - Deutsche Bank Michael Ha - Baird Jack Slevin - Jefferies Whit Mayo - Leerink Partners Jenny Shen - BT ...

Agilon Health (AGL) reported $1.48 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 29%. EPS of -$0.07 for the same period compares to -$0.04 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.56 billion, representing a surprise of -4.85%. The company has not delivered EPS surprise, with the consensus EPS estimate being -$0.07.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...